KOTAK SECURITIES ON CIPLA
β’ Rating: Maintain Buy
β’ Target Price: βΉ1,675/share
β’ Rating: Maintain Buy
β’ Target Price: βΉ1,675/share
NOMURA ON INDIAMART INTERMESH
β’ Rating: Upgrade to Neutral
β’ Target Price: Hiked to βΉ1,840/share
β’ Rating: Upgrade to Neutral
β’ Target Price: Hiked to βΉ1,840/share
NOMURA ON PAYTM
β’ Rating: Maintain Buy
β’ Target Price: Hiked to βΉ2,300/share
β’ Rating: Maintain Buy
β’ Target Price: Hiked to βΉ2,300/share
CLSA ON L&T
β’ Rating: Outperform
β’ Target Price: βΉ4,842/share
β’ E&C execution grew 22% YoY despite West Asia disruptions.
β’ West Asia business grew 26% and India business rose 16%.
β’ FY27 guidance retained: 10β12% growth in orders and execution, with flat margins.
β’ Rating: Outperform
β’ Target Price: βΉ4,842/share
β’ E&C execution grew 22% YoY despite West Asia disruptions.
β’ West Asia business grew 26% and India business rose 16%.
β’ FY27 guidance retained: 10β12% growth in orders and execution, with flat margins.
Larsen and Toubro L&T in Focus
Maintains growth and order Outlook
Working capital improvements see despite middle east crisis
Order pick up seen ahead with margins improvement in Q4
Maintains growth and order Outlook
Working capital improvements see despite middle east crisis
Order pick up seen ahead with margins improvement in Q4
BAJAJ AUTO says
Lost Some Mkt Share In 100/125cc Segment, 150cc Segment Has Seen A Turnaround Recently
Lost Some Mkt Share In 100/125cc Segment, 150cc Segment Has Seen A Turnaround Recently
β€1
BAJAJ AUTO - Margins boosted by PLI Scheme, Market Share losses continue -mix brokerage reviews - Stock off highs
1 PLI on Electric Scooters
2 PLI on Export
3 Higher Royalty income in Q2
These 3 factors lead to better margins, may not be the case in coming quarters
1 PLI on Electric Scooters
2 PLI on Export
3 Higher Royalty income in Q2
These 3 factors lead to better margins, may not be the case in coming quarters
β€1
NEW LISTING IPO
JIO PLATFORMS LIMITED β IPO LISTING
β’ Issue Price: βΉ1,119.00
β’ Listing Price: βΉ1,358.00
β’ Listing Gain: 21.36% (+βΉ239.00 per share)
JIO PLATFORMS LIMITED β IPO LISTING
β’ Issue Price: βΉ1,119.00
β’ Listing Price: βΉ1,358.00
β’ Listing Gain: 21.36% (+βΉ239.00 per share)
NEW LISTING IPO
PARAS HEALTHCARE LIMITED β IPO LISTING
β’ Issue Price: βΉ693.00
β’ Listing Price: βΉ720.00
β’ Listing Gain: 3.90% (+βΉ27.00 per share)
PARAS HEALTHCARE LIMITED β IPO LISTING
β’ Issue Price: βΉ693.00
β’ Listing Price: βΉ720.00
β’ Listing Gain: 3.90% (+βΉ27.00 per share)
MOTILAL OSWAL ON JIO
Initiates 'Buy' Call, Target Price At 1,350/Sh, Sees 21% Upside
Initiates 'Buy' Call, Target Price At 1,350/Sh, Sees 21% Upside
HINDUSTAN UNILEVER Q2 FY27
β’ Net Profit: βΉ2,796 Cr vs βΉ2,694 Cr YoY (β4%) | vs βΉ2,680 Cr QoQ (β4%)
β’ Revenue: βΉ18,226 Cr vs βΉ15,919 Cr YoY (β14%) | vs βΉ17,341 Cr QoQ (β5%)
β’ Other Income: βΉ160 Cr vs βΉ147 Cr YoY | vs βΉ188 Cr QoQ
β’ EPS: βΉ11.87 vs βΉ11.43 YoY (β4%) | vs βΉ11.38 QoQ (β4%)
β’ Net Profit: βΉ2,796 Cr vs βΉ2,694 Cr YoY (β4%) | vs βΉ2,680 Cr QoQ (β4%)
β’ Revenue: βΉ18,226 Cr vs βΉ15,919 Cr YoY (β14%) | vs βΉ17,341 Cr QoQ (β5%)
β’ Other Income: βΉ160 Cr vs βΉ147 Cr YoY | vs βΉ188 Cr QoQ
β’ EPS: βΉ11.87 vs βΉ11.43 YoY (β4%) | vs βΉ11.38 QoQ (β4%)
β€1
SBI LIFE Q2 CONCALL : H1 VNB JUMPS 19%, PAT GROWS 17%; MANAGEMENT RETAINS 14β15% FY27 PREMIUM GROWTH GUIDANCE & 26β28% VNB MARGIN TARGET
β’ MANAGEMENT REITERATES FY27 INDIVIDUAL RATED PREMIUM (IRP) GROWTH GUIDANCE OF 14β15%, DESPITE 12% GROWTH DURING H1 FY27
β’ MANAGEMENT EXPECTS STRONGER PREMIUM GROWTH IN Q3 & H2 FY27, SUPPORTED BY BANCA CHANNEL MOMENTUM, AGENCY RECOVERY & HIGHER NON-ULIP SALES
β’ MANAGEMENT RETAINS FY27 VALUE OF NEW BUSINESS (VNB) MARGIN GUIDANCE OF 26β28%, DESPITE Q2 MARGIN IMPROVING TO 29.3%
β’ MANAGEMENT TARGETS ULIP CONTRIBUTION OF APPROXIMATELY 63% FOR FY27, WHILE EXPANDING HIGHER-MARGIN GUARANTEED SAVINGS, ANNUITY & PROTECTION PRODUCTS
β’ MANAGEMENT PLANS TO LAUNCH A REGULAR-PAY DEFERRED ANNUITY PRODUCT IN Q3 FY27, SUPPORTING NON-PAR SAVINGS GROWTH & PRODUCT DIVERSIFICATION
β’ H1 FY27 NEW BUSINESS PREMIUM GREW 10% YOY TO βΉ20,260 CR, WHILE GROSS WRITTEN PREMIUM INCREASED 13% TO βΉ48,400 CR
β’ H1 ANNUALISED PREMIUM EQUIVALENT (APE) GREW 18% YOY TO βΉ11,750 CR, WHILE INDIVIDUAL RATED PREMIUM INCREASED 12% TO βΉ9,720 CR
β’ H1 VALUE OF NEW BUSINESS JUMPED 19% YOY TO βΉ3,270 CR, WITH VNB MARGIN AT 27.9%, SUPPORTED BY IMPROVING PRODUCT MIX
β’ H1 NET PROFIT GREW 17% YOY TO βΉ1,270 CR, DESPITE βΉ530 CR GST-RELATED IMPACT; MANAGEMENT INDICATED ADJUSTED PAT OF βΉ1,690 CR, UP 39%
β’ GUARANTEED NON-PAR SAVINGS GREW 27% TO βΉ2,470 CR, WHILE ULIP CONTRIBUTION DECLINED TO 62% FROM 65% IN H1 FY26
β’ INDIVIDUAL PROTECTION APE GREW 16%, PURE PROTECTION APE INCREASED 26% & GROUP PROTECTION APE SURGED 134% TO βΉ1,600 CR
β’ SBI BANCASSURANCE CONTRIBUTED 53% OF TOTAL APE, WHILE AGENCY INDIVIDUAL APE GREW 12% TO βΉ3,200 CR & OTHER DISTRIBUTION CHANNELS EXPANDED 67%
β’ EMBEDDED VALUE GREW 15% YOY TO βΉ87,350 CR, WHILE OPERATING RETURN ON EMBEDDED VALUE STOOD AT 18.8% & AUM INCREASED 9% TO βΉ5.3 LAKH CR
β’ COMPANY MAINTAINED 22.6% PRIVATE MARKET SHARE IN INDIVIDUAL RATED PREMIUM, WHILE 13TH-MONTH & 25TH-MONTH PERSISTENCY IMPROVED TO 87.6% & 78.4%
β’ MANAGEMENT REMAINS POSITIVE ON H2 PREMIUM GROWTH, PROTECTION & ANNUITY DEMAND, BUT GST-RELATED COST PRESSURES, AGENCY RECOVERY, REGULATORY CHANGES & DELIVERY OF FY27 GROWTH GUIDANCE REMAIN KEY MONITORABLES
β’ MANAGEMENT REITERATES FY27 INDIVIDUAL RATED PREMIUM (IRP) GROWTH GUIDANCE OF 14β15%, DESPITE 12% GROWTH DURING H1 FY27
β’ MANAGEMENT EXPECTS STRONGER PREMIUM GROWTH IN Q3 & H2 FY27, SUPPORTED BY BANCA CHANNEL MOMENTUM, AGENCY RECOVERY & HIGHER NON-ULIP SALES
β’ MANAGEMENT RETAINS FY27 VALUE OF NEW BUSINESS (VNB) MARGIN GUIDANCE OF 26β28%, DESPITE Q2 MARGIN IMPROVING TO 29.3%
β’ MANAGEMENT TARGETS ULIP CONTRIBUTION OF APPROXIMATELY 63% FOR FY27, WHILE EXPANDING HIGHER-MARGIN GUARANTEED SAVINGS, ANNUITY & PROTECTION PRODUCTS
β’ MANAGEMENT PLANS TO LAUNCH A REGULAR-PAY DEFERRED ANNUITY PRODUCT IN Q3 FY27, SUPPORTING NON-PAR SAVINGS GROWTH & PRODUCT DIVERSIFICATION
β’ H1 FY27 NEW BUSINESS PREMIUM GREW 10% YOY TO βΉ20,260 CR, WHILE GROSS WRITTEN PREMIUM INCREASED 13% TO βΉ48,400 CR
β’ H1 ANNUALISED PREMIUM EQUIVALENT (APE) GREW 18% YOY TO βΉ11,750 CR, WHILE INDIVIDUAL RATED PREMIUM INCREASED 12% TO βΉ9,720 CR
β’ H1 VALUE OF NEW BUSINESS JUMPED 19% YOY TO βΉ3,270 CR, WITH VNB MARGIN AT 27.9%, SUPPORTED BY IMPROVING PRODUCT MIX
β’ H1 NET PROFIT GREW 17% YOY TO βΉ1,270 CR, DESPITE βΉ530 CR GST-RELATED IMPACT; MANAGEMENT INDICATED ADJUSTED PAT OF βΉ1,690 CR, UP 39%
β’ GUARANTEED NON-PAR SAVINGS GREW 27% TO βΉ2,470 CR, WHILE ULIP CONTRIBUTION DECLINED TO 62% FROM 65% IN H1 FY26
β’ INDIVIDUAL PROTECTION APE GREW 16%, PURE PROTECTION APE INCREASED 26% & GROUP PROTECTION APE SURGED 134% TO βΉ1,600 CR
β’ SBI BANCASSURANCE CONTRIBUTED 53% OF TOTAL APE, WHILE AGENCY INDIVIDUAL APE GREW 12% TO βΉ3,200 CR & OTHER DISTRIBUTION CHANNELS EXPANDED 67%
β’ EMBEDDED VALUE GREW 15% YOY TO βΉ87,350 CR, WHILE OPERATING RETURN ON EMBEDDED VALUE STOOD AT 18.8% & AUM INCREASED 9% TO βΉ5.3 LAKH CR
β’ COMPANY MAINTAINED 22.6% PRIVATE MARKET SHARE IN INDIVIDUAL RATED PREMIUM, WHILE 13TH-MONTH & 25TH-MONTH PERSISTENCY IMPROVED TO 87.6% & 78.4%
β’ MANAGEMENT REMAINS POSITIVE ON H2 PREMIUM GROWTH, PROTECTION & ANNUITY DEMAND, BUT GST-RELATED COST PRESSURES, AGENCY RECOVERY, REGULATORY CHANGES & DELIVERY OF FY27 GROWTH GUIDANCE REMAIN KEY MONITORABLES
β€1
HUL Q2: RETAINS FY27 EBITDA MARGIN GUIDANCE AT 22β24%; EXPECTS BETTER GROWTH THAN FY26
β’ FY27 Outlook: Expects better performance than FY26
β’ Demand: Consumer demand remains resilient, supported by healthy macroeconomic indicators
β’ EBITDA Margin Guidance: Retained at 22β24% (Consolidated)
β’ Commodity Costs: Raw material inflationary pressures expected to persist in the near term
β’ Growth Strategy: Focus on competitive, volume-led profitable growth under the WINI strategy
β’ Portfolio & Distribution: Continued transformation to drive business growth
β’ Profitability: Aims to balance volume growth and profitability amid commodity cost pressures
β’ FY27 Outlook: Expects better performance than FY26
β’ Demand: Consumer demand remains resilient, supported by healthy macroeconomic indicators
β’ EBITDA Margin Guidance: Retained at 22β24% (Consolidated)
β’ Commodity Costs: Raw material inflationary pressures expected to persist in the near term
β’ Growth Strategy: Focus on competitive, volume-led profitable growth under the WINI strategy
β’ Portfolio & Distribution: Continued transformation to drive business growth
β’ Profitability: Aims to balance volume growth and profitability amid commodity cost pressures
HUL β Q2 HIGHLIGHTS
β’ FY27 performance expected to be better than FY26, supported by portfolio and channel transformation.
β’ Underlying consumer demand remains resilient, backed by healthy macroeconomic indicators.
β’ FY27 consolidated EBITDA margin guidance retained at 22β24%.
β’ Raw material inflationary pressures expected to persist in the near term.
β’ Focus remains on competitive, volume-led profitable growth under the WINI strategy.
β’ FY27 performance expected to be better than FY26, supported by portfolio and channel transformation.
β’ Underlying consumer demand remains resilient, backed by healthy macroeconomic indicators.
β’ FY27 consolidated EBITDA margin guidance retained at 22β24%.
β’ Raw material inflationary pressures expected to persist in the near term.
β’ Focus remains on competitive, volume-led profitable growth under the WINI strategy.
β€1
HUL Q2 FY27 β SEGMENT-WISE PERFORMANCE π
HOME CARE
β’ Revenue: βΉ6,882 Cr | +21.44% YoY | +5.09% QoQ
β’ Segment Profit: βΉ1,070 Cr | +1.90% YoY | -1.74% QoQ
BEAUTY & WELLBEING
β’ Revenue: βΉ3,935 Cr | +16.19% YoY | +5.85% QoQ
β’ Segment Profit: βΉ1,242 Cr | +20.47% YoY | +11.63% QoQ
PERSONAL CARE
β’ Revenue: βΉ2,618 Cr | +7.91% YoY | -0.23% QoQ
β’ Segment Profit: βΉ443 Cr | -9.03% YoY | -9.03% QoQ
FOODS
β’ Revenue: βΉ3,849 Cr | +8.61% YoY | +1.18% QoQ
β’ Segment Profit: βΉ834 Cr | +15.67% YoY | +20.52% QoQ
OTHERS (INCLUDING EXPORTS)
β’ Revenue: βΉ259 Cr | +10.90% YoY | -4.43% QoQ
β’ Segment Profit: βΉ46 Cr | -12.77% YoY | +2.22% QoQ
HOME CARE
β’ Revenue: βΉ6,882 Cr | +21.44% YoY | +5.09% QoQ
β’ Segment Profit: βΉ1,070 Cr | +1.90% YoY | -1.74% QoQ
BEAUTY & WELLBEING
β’ Revenue: βΉ3,935 Cr | +16.19% YoY | +5.85% QoQ
β’ Segment Profit: βΉ1,242 Cr | +20.47% YoY | +11.63% QoQ
PERSONAL CARE
β’ Revenue: βΉ2,618 Cr | +7.91% YoY | -0.23% QoQ
β’ Segment Profit: βΉ443 Cr | -9.03% YoY | -9.03% QoQ
FOODS
β’ Revenue: βΉ3,849 Cr | +8.61% YoY | +1.18% QoQ
β’ Segment Profit: βΉ834 Cr | +15.67% YoY | +20.52% QoQ
OTHERS (INCLUDING EXPORTS)
β’ Revenue: βΉ259 Cr | +10.90% YoY | -4.43% QoQ
β’ Segment Profit: βΉ46 Cr | -12.77% YoY | +2.22% QoQ
JIO PLATFORMS BECOMES INDIA'S 2ND LARGEST LISTED CO AT SETTLED PRICE
β€2
π¨ HUL Q2 FY27 β ACTUAL VS ESTIMATES (CONS.)
π’ Net Profit: βΉ2,790 Cr vs βΉ2,784 Cr est. (+0.22%)
π’ Revenue: βΉ18,226 Cr vs βΉ17,582 Cr est. (+3.66%)
π’ EBITDA: βΉ4,089 Cr vs βΉ4,018 Cr est. (+1.77%)
π΄ EBITDA Margin: 22.4% vs 23.1% est. (Miss by 70 bps)
π’ Net Profit: βΉ2,790 Cr vs βΉ2,784 Cr est. (+0.22%)
π’ Revenue: βΉ18,226 Cr vs βΉ17,582 Cr est. (+3.66%)
π’ EBITDA: βΉ4,089 Cr vs βΉ4,018 Cr est. (+1.77%)
π΄ EBITDA Margin: 22.4% vs 23.1% est. (Miss by 70 bps)
β€3
SEBI CHIEF NEED MORE IMPROVEMENT IN FII ON BOARDING PROCESS
WE ARE COONTINOUSLY MEETING FII FOR FEEDBACK AND TROUBLE SPOTS
WE ARE COONTINOUSLY MEETING FII FOR FEEDBACK AND TROUBLE SPOTS
β€4π₯1